Representatives from drug companies are undergoing some hard times, as physicians increasingly are closing their doors to them, or seeing them only via an appointment.
Subsequently, the number of drug reps is predicted to fall from about 102,000 at its peak in 2007, to 75,000 by 2012.
There are a variety of reasons for this, including the fact that more doctors simply don’t trust the information that’s presented, to medical schools (more…)